Clinical Trials Directory

Trials / Completed

CompletedNCT01744301

Acid Suppressing Drug Seizure Epidemiology Study

A Cohort Study With a Nested Case Control Analysis on the Association Between Acid-suppressing Drugs and Seizures Using THIN Database in the UK

Status
Completed
Phase
Study type
Observational
Enrollment
8,605 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is 1. to estimate the incidence of seizure in the general population and stratified by epilepsy status 2. To estimate the relative risk of seizure associated with use of proton pump inhibitors and histamine 2 receptor antagonist and stratified by epilepsy status

Detailed description

A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK

Conditions

Interventions

TypeNameDescription
DRUGRisk of seizurePatients newly prescribed PPI and H2RA, respectively

Timeline

Start date
2013-03-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-12-06
Last updated
2016-09-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01744301. Inclusion in this directory is not an endorsement.

Acid Suppressing Drug Seizure Epidemiology Study (NCT01744301) · Clinical Trials Directory